Biotech - Press Releases

Date	Title	Company
03-Aug-2020	UCL Technology Fund announces first close of £100m Fund 2	UCL Technology Fund
03-Aug-2020	Amryt Pharma to Host Key Opinion Leader Call on Epidermolysis Bullosa Disease Landscape	Amryt Pharma
03-Aug-2020	Enterome scientists contribute to extensive new genomic and proteomic catalog to enhance analysis of the gut microbiome and understanding of its role in human health	ENTEROME SA,
03-Aug-2020	Novartis Cosentyx® receives EU approval for first-line systemic treatment in pediatric psoriasis	Novartis
03-Aug-2020	ASLAN PHARMACEUTICALS APPOINTS KENNETH KOBAYASHI, MD, AS CHIEF MEDICAL OFFICER	ASLAN Pharmaceuticals
03-Aug-2020	Lilly Initiates Phase 3 Trial of LY-CoV555 for Prevention of COVID-19 at Long-Term Care Facilities in Partnership with the National Institute of Allergy and Infectious Diseases (NIAID)	Eli Lilly
03-Aug-2020	New Publication in Nature Cancer Demonstrates Signatera's Ability to Evaluate Tumor Response to Immunotherapy	Natera, Inc.
03-Aug-2020	CASI Pharmaceuticals To Report Second Quarter 2020 Financial Results And Host Conference Call August 10, 2020	CASI Pharmaceuticals, Inc.
03-Aug-2020	ArcherDX and UCL Extend TRACERx Program Collaboration to Evaluate Cancer Evolution	ArcherDX
03-Aug-2020	Kadimastem Reports Positive Interim Results of Cohort B of its AstroRx® Phase 1/2a Clinical Trial in ALS	Kadimastem
03-Aug-2020	Syndax Announces Participation in BTIG Virtual Biotechnology Conference	Syndax Pharmaceuticals, Inc.
03-Aug-2020	NBE-Therapeutics Appoints Bertrand Damour as Chief Executive Officer	NBE-Therapeutics
03-Aug-2020	Enterome scientists contribute to extensive new genomic and proteomic catalog to enhance analysis of the gut microbiome and understanding of its role in human health	Enterome
03-Aug-2020	Innovent Announces First Patient Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody in China	Innovent Biologics, Inc.
03-Aug-2020	VistaGen Therapeutics Announces Pricing of $12.5 Million Underwritten Public Offering of Common Stock	VistaGen Therapeutics
03-Aug-2020	Innovent Announces First Patient Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody in China	Innovent Biologics, Inc.
02-Aug-2020	Immunic, Inc. Reports Positive Top-line Data from Phase 2 EMPhASIS Trial of IMU-838 in Patients with Relapsing-Remitting Multiple Sclerosis	Immunic, Inc.
02-Aug-2020	Varian to Combine with Siemens Healthineers in $16.4 Billion All-Cash Transaction	Varian
31-Jul-2020	Coronavirus (COVID-19) Update: FDA Authorizes First Two Tests that Estimate a Patient's Antibodies from Past SARS-CoV-2 Infection	U.S. Food and Drug Administration
31-Jul-2020	Synlogic to Present at Upcoming Virtual Banking Conferences	Synlogic, Inc.